Lazard Asset Management LLC bought 5.40 million shares of SINOPHARM (01099) on the SEHK open market at an average of HKD 16.19 per share on October 30, 2026, involving about HKD 87.39 million; this was an on-exchange active trade matched on the SEHK open market and therefore a direct secondary-market dealing.
Prior to the acquisition, Lazard Asset Management LLC’s long position in SINOPHARM was 185.96 million shares, representing 13.86%; following the acquisition, the holding changed to 191.36 million shares, with the long position ratio rising to 14.26%.